Moderna sues Pfizer and its German partner BioNTech for Patent infringement in The development of The first COVID-19 Vaccine Approved in The United States, allegedly copied technology that moderna developed years before the pandemic.
Pfizer shares It fell 1.4% before bell While BioNTech down about 2%.
The lawsuit has been filed, seeking unspecified monetary damages in US District Court in Massachusetts District Court of Düsseldorf in Moderna Germany said in a news Release on Friday.
“We are bringing these lawsuits to protect the innovative mRNA technology The platform we created and invested billions of dollar in creatingand received a patent during the decade leading up to the COVID-19 pandemic,” said Moderna CEO Stefan Bansel in Statement.
moderna company, on Own, partnership of Both Pfizer Inc. and BioNTech SE two of The first vaccine development groups for The novel Corona Virus.
Just a decade, Moderna, based in Cambridge, Massachusetts, was innovative in Messenger RNA (mRNA) vaccine technology that enabled unprecedented speed in COVID-19 vaccine development.
Previous approval process took Years are completed in months, thanks in large part to the hack in mRNA vaccines, which teach human cells how To make a protein that would trigger immune response.
Germany-based BioNTech owns also he was working in This field when you participate with American pharmaceutical giant Pfizer.
The US Food and Drug Administration has granted a state of emergency use to delegate for COVID-19 Vaccine first For Pfizer / BioNTech in December 2020, then one A week later to Moderna.
He brought Moderna’s COVID vaccine – its only commercial product in 10.4 billion dollars in this income year While getting the Pfizer vaccine in About $22 billion.
Moderna alleges that Pfizer/BioNTech copied mRNA without permission technology That Moderna had a patent between 2010 and 2016, long before the emergence of COVID-19 in 2019 exploded in global awareness – awareness in early 2020.
early in pandemic, Moderna said it will not apply its COVID-19 patents to help Others are developing their own vaccines, in particular for Low and middle income countries. But in Moderna said in March 2022 that it expects companies like Pfizer and BioNTech to respect its thought property rights. She will not ask for compensation for Any activity before March 8, 2022.
Patent litigation is not uncommon in early stages of new technology.
Pfizer and BioNTech already facing Multiple lawsuits from other companies who He says the partnership vaccine is in violation on their patents. Pfizer/BioNTech said it would vigorously defend its patents.
German CureVac, for Model, also lawsuit against Biotechnology in Germany in July. BioNTech responded in statement that his work I was original.
Moderna has also sued for Patent infringement in The United States has an ongoing conflict with US National Institutes of health over mRNA rights technology.
Moderna said in a statement on Friday that Pfizer/Bioantek has designated two types of mental property.
One of them includes the mRNA structure that Moderna says Scientists began to develop in 2010 was first To validate in human experiences in 2015.
Pfizer and BioN Tech took Four different vaccine candidates in clinical trials, which included options would direct clear of Our innovative modern path. However, Pfizer and BioNTech eventually decided to move forward with A vaccine that has the same exact chemical modification of the mRNA as the vaccine,” Moderna said in her statement.
The second The alleged infringement includes coding of a full-height spike Moderna protein says her scholars developed While creating vaccine for Corona virus that causes Middle East Respiratory Syndrome (MERS).
Although the MERS vaccine never went away marketthat it development Moderna helped get off the ground quickly out COVID-19 vaccine.
Pfizer said the company did not provide it with services and that they were unable to do so comment at this time.
